Relapsed and/or Refractory Diffuse Large B-cell Lymphoma Including With Myc Alterations (DBCOND0088162)
Identifiers
- Synonyms
- Not Available
Associated Data
- Indicated Drugs and Targets
- Not Available
- Clinical Trials
Identifier Title Drug(s) Purpose Phase Status NCT02674750 Study to Evaluate the Efficacy and Safety of CUDC-907 in Patients With RR DLBCL, Including Patients With MYC Alterations treatment 2 completed